drug Archives - JLM-BioCity

Oramed Completes Patient Enrollment of its Pivotal Phase 3 Oral Insulin Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, has completed patient enrollment for its Phase 3 ORA-D-013-1 study…

To RSVP, contact Sara Gdanski, JLM-BioCity Corporate Relations Manager at 058-7922882

or email her at: sara.gdanski1 AT gmail.com

More JLM BioCity events coming soon…

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

- Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

The JLM Biocity networking events on Zoom keeps getting better. For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

- Ian Solomon CTO, OmnySense Ltd.

JLM-BioCity's events are well organized with a professional approach. You can feel a "homey" atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

- Dror Chevion CEO, Concenter BioPharma

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

- Immanuel Lerner CEO, Pepticom

Excellent event. Good speakers, interesting audience. Well done!

- Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

- Zeev Malyutin, Protein Department Head, Merck KGaA

Such an interesting lecture and great people attending!

- Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

Interesting - I could see it helping people network - a good thing!

- Jonathan Miller, Founder, President, and Designer, U-Step, Neurological Walking Aids

Great atmosphere, great people.

- Yael Ophir, Executive Director, HealthIL

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

Very informative and eye-opening event. Thank you for the great hospitality.

- Hemda Idel, founder, SLEEP ASAP

one of the best meetups organizations and a very important source of information and connections for startups.

Tal Or, Co-Founder, ATLASense Biomed Ltd.

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

Alexander Naslednikov, Founder and CEO, Med.me

<< Prev

Next >>

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

Oramed Completes Patient Enrollment of its Pivotal Phase 3 Oral Insulin Study

Strategic Partners

Platinum

Gold

Silver

Contact us at

Follow us

Copyright © 2020 JLM-BioCity | All rights reserved